Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Emtricitabine | HCID 60877 | — |
| Reactant | Butyrate | HCID 104775 | — |
| Reactant | (+)-2′-Deoxy-3′-thia-5-fluorocytidine | HCID 454858 | — |
| Solvent | Phosphate | HCID 1061 | — |
| Solvent | Isopropanol | HCID 3776 | — |
| Product | HCID 131725250 | HCID 131725250 | — |
Reaction Steps
The following example illustrates the state of the art using high amounts of enzyme catalysts in a of homogeneous system. To a solution of 1 ml of Altus PLE solution 650 units/ml from Altus Biologics, Inc. in 39 ml of 0.3 M phosphate buffer (pH 7.5) was added 10 ml of 10% FTC butyrate in isopropanol. The resulting mixture was stirred 24˜26° C. and the reaction progress was monitored by HPLC. The conversion reached 51% and the optical purity of the remaining chiral nonracemic ester compound was greater than 99% (48% chemical yield) after a 22 h reaction. These results are based on HPLC analysis of the remaining chiral nonracemic ester compound. The aqueous layer included hydrolyzed products (+)-FTC and (−)-FTC. The ratio of (+)-FTC and (−)-FTC was 96.6 to 3.4. The organic layer was evaporated to give 0.457 g of (−)-FTC butyrate.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06979561B1 |
|---|
| Source dataset | uspto-grants-2005_12 |
|---|
| ORD ID | ord-6bdf46c6adba4db291176130a07d6ad7 |
|---|
| Source note | uspto-grants-2005_12 |
|---|